share_log

SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sessa Capital (Master), L.P.

SAB Biotherapeutics | 4:持股變動聲明-董事 Sessa Capital (Master), L.P.

SEC announcement ·  2023/11/14 16:08
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息